Classification of lung cancer histology by gold nanoparticle sensors

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 8, Issue 5, 2012, Pages 580-589

  Barash, Orna ^a   Peled, Nir ^b,c   Tisch, Ulrike ^a   Bunn, Paul A ^b   Hirsch, Fred R ^b   Haick, Hossam ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Gold nanoparticle; Histology; Lung cancer; Sensor; Volatile organic compound

Indexed keywords

CHEMICAL NATURE; DEVICE PROFILE; DIFFERENTIAL DIAGNOSIS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GOLD NANOPARTICLE; GOLD NANOPARTICLES; HEADSPACES; LUNG CANCER; LUNG CANCER CELLS; LUNG NODULE; PROOF OF CONCEPT; SENSING SIGNALS; SQUAMOUS CELL CARCINOMA;

CELLS; CYTOLOGY; DIAGNOSIS; DISEASES; GAS CHROMATOGRAPHY; HISTOLOGY; METAL NANOPARTICLES; SENSORS; VOLATILE ORGANIC COMPOUNDS;

BIOLOGICAL ORGANS;

GOLD NANOPARTICLE; VOLATILE ORGANIC COMPOUND;

ARTICLE; CANCER CELL; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER SCREENING; CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NODULE; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MASS FRAGMENTOGRAPHY; SUPPORT VECTOR MACHINE;

BIOSENSING TECHNIQUES; EARLY DETECTION OF CANCER; GOLD; HUMANS; LUNG NEOPLASMS; NANOPARTICLES; VOLATILE ORGANIC COMPOUNDS;

EID: 84862690842     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2011.10.001     Document Type: Article

References (43)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M.J. Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249.
2. Vallieres E., Shepherd F.A., Crowley J., Van Houtte P., Postmus P.E., Carney D., et al. The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2009, 4:1049-1059.
3. Peled N., Yoshida K., Wynes M.W., Hirsch F.R. Predictive and prognostic markers for epidermal growth factor receptor inhibitor therapy in non-small cell lung cancer. Ther Adv Med Oncol 2009, 1:137-144.
4. Holty J.E., Kuschner W.G., Gould M.K. Accuracy of transbronchial needle aspiration for mediastinal staging of non-small cell lung cancer: a meta-analysis. Thorax 2005, 60:949-955.
5. Peng G., Hakim M., Broza Y.Y., Billan S., Abdah-Bortnyak R., Kuten A., et al. Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. Br J Cancer 2010, 103:542-551.
6. Peng G., Tisch U., Adams O., Hakim M., Shehada N., Broza Y.Y., et al. Diagnosing lung cancer in exhaled breath using gold nanoparticles. Nat Nanotechnol 2009, 4:669-673.
7. Chen X., Xu F., Wang Y., Pan Y., Lu D., Wang P., et al. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis. Cancer 2007, 110:835-844.
8. Barash O., Peled N., Hirsch F.R., Haick H. Sniffing the unique ' odor print' of non-small-cell lung cancer with gold nanoparticles. Small 2009, 5:2618-2624.
9. Wehinger A., Schmid A., Mechtcheriakov S., Ledochowski M., Grabmer C., Gastl G.A., et al. Lung cancer detection by proton transfer reaction mass-spectrometric analysis of human breath gas. Int J Mass Spectrom 2007, 265:49-59.
10. Phillips M., Gleeson K., Hughes J.M.B., Greenberg J., Cataneo R.N., Baker L., et al. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet 1999, 353:1930-1933.
11. Gordon S.M., Szidon J.P., Krotoszynski B.K., Gibbons R.D., Oneill H.J. Volatile organic-compounds in exhaled air from patients with lung-cancer. Clin Chem 1985, 31:1278-1282.
12. Preti G., Labows J.N., Kostelc J.G., Aldinger S., Daniele R. Analysis of lung air from patients with bronchogenic carcinoma and controls using gas chromatography-mass spectrometry. J Chromatogr 1988, 432:1-11.
13. O'Neill H.J., Gordon S.M., O'Neill M.H., Gibbons R.D., Szidon J.P. A computerized classification technique for screening for the presence of breath biomarkers in lung cancer. Clin Chem 1988, 34:1613-1618.
14. Tisch U., Haick H. Arrays of chemisensitive monolayer-capped metallic nanoparticles for diagnostic breath testing. Rev Chem Eng 2011, 26:171-179.
15. Shuster G., Gallimidi Z., Heyman-Reiss A., Dovgolevsky E., Billan S., Abdah-Bortnyak R., et al. Classification of breast cancer precursors through exhaled breath. Breast Cancer Res Treat 2011, 126:791-796.
16. Hakim M., Billan S., Tisch U., Peng G., Dvrokind I., Abdah-Bortnyak R., et al. Diagnosis of head-and-neck-cancer from exhaled breath. Br J Cancer 2011, 104:1649-1655.
17. Tisch U., Haick H. Nanomaterials for cross-reactive sensor arrays. MRS Bull 2010, 35:797.
18. Tisch U., Haick H. Sensors based on monolayer-capped metal nanoparticles. Chemical sensors. Vol. 2: Nanstructured materials 2010, 141-202. Momentum Press, LLC, New York. G. Korotcenkov (Ed.).
19. Alberts B., Johnson A., Lewis J. Molecular biology of the cell 2002, Garland Publishing, New York. 4th ed.
20. Singer S.J., Nicolson G.L. The fluid mosaic model of the structure of cell membranes. Science 1972, 175:720-731.
21. Kneepkens C.M., Lepage G., Roy C.C. The potential of the hydrocarbon breath test as a measure of lipid peroxidation. Free Radic Biol Med 1994, 17:127-160.
22. Vousden K.H. Ryan KM. p53 and metabolism. Nat Rev Cancer 2009, 9:691-700.
23. Okunieff P., Fenton B., Chen Y. Past, present, and future of oxygen in cancer research. Adv Exp Med Biol 2005, 566:213-222.
24. Hakim M., Billan S., Tisch U., Peng G., Dvrokind I., Marom O., et al. Diagnosis of head-and-neck cancer from exhaled breath. Br J Cancer 2011, 104:1649-1655.
25. Dovgolevsky E., Haick H. Direct observation of the transition point between quasi-spherical and cubic nanoparticles in two-step seed-mediated growth method. Small 2008, 4:2059-2066.
26. Dovgolevsky E., Tisch U., Haick H. Chemically sensitive resistors based on monolayer-capped cubic nanoparticles: towards configurable nanoporous sensors. Small 2009, 5:1158-1161.
27. Dovgolevsky E., Convolina G., Tisch U., Haick H. Monolayer-capped cubic platinum nanoparticles for sensing nonpolar analytes in highly humid atmospheres. J Phys Chem C 2010, 114:14042-14049.
28. Cortes C., Vapnik V. Support-vector networks. Machine Learning 1995, 30:273-297.
29. Hall M., Frank E., Holmes G., Pfahringer B., Reutemann P., Witten I.H. The WEKA data mining software: an update. SIGKDD Explorations 2009, 11:10-18.
30. Haick H. Chemical sensors based on molecularly modified metallic nanoparticles. J Phys D 2007, 40:7173-7186.
31. Travis W.D., Travis L.B., Devesa S.S. Lung cancer. Cancer 1995, 75(Suppl. 1):191-202.
32. Bryant A., Cerfolio R.J. Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer. Chest 2007, 132:185-192.
33. Filipiak W., Sponring A., Filipiak A., Ager C., Schubert J., Miekisch W., et al. TD-GC-MS analysis of volatile metabolites of human lung cancer and normal cells in vitro. Cancer Epidemiol Biomark Prev 2010, 19:182-195.
34. Filipiak W., Sponring A., Mikoviny T., Ager C., Schubert J., Miekisch W., et al. Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro. Cancer Cell Int 2008, 8:1-11.
35. Sponring A., Filipiak W., Ager C., Schubert J.K., Miekisch W., Amann A., et al. Analysis of volatile organic compounds (VOCs) in the headspace of NCI-H1666 lung cancer cells. Cancer Biomark 2010, 7:153-161.
36. Sponring A., Filipiak W., Mikoviny T., Ager C., Schubert J.K., Miekisch W., et al. Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro. Anticancer Res 2009, 29:419-426.
37. Gatenby R.A., Gillies R.J. Why do cancers have high aerobic glycolysis?. Nat Rev Cancer 2004, 4:891-899.
38. Patel M., Lu L., Zander D.S., Sreerama L., Coco D., Moreb J.S. ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors. Lung Cancer 2008, 59:340-349.
39. Hsu P.P., Sabatini D.M. Cancer cell metabolism: Warburg and beyond. Cell 2008, 134:703-707.
40. Wallace L., Pellizzari E., Hartwell T.D., Perritt R., Ziegenfus R. Exposures to benzene and other volatile compounds from active and passive smoking. Arch Environ Health 1987, 42:272-279.
41. Barbone F., Bovenzi M., Cavallieri F., Stanta G. Cigarette smoking and histologic type of lung cancer in men. Chest 1997, 112:1474-1479.
42. Joseph Y., Guse B., Yasuda A., Vossmeyer T. Chemiresistor coatings from Pt- and Au-nanoparticle/nonanedithiol films: sensitivity to gases and solvent vapors. Sens Actuat B 2004, B98:188-195.
43. Kroemer G., Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 2008, 13:472-482.